Director Michelle Nettles buys 1,800 RXO shares at $27.89; RXO posts -18.1% annual revenue decline and -$243M net loss.
Director Michelle Nettles purchased 1,800 shares of RXO at $27.89 on 2024-11-12, increasing her holdings by 13.4% from 13,385 to 15,185 shares. This acquisition occurs against a backdrop of significant operational headwinds: RXO reported annual revenue decline of -18.1% and a net loss of -$243.0M, with a P/E ratio of 916.33 reflecting the unprofitable state. The company's stock is currently trading at $27.49, down 13.8% from its 52-week high of $31.90. While the purchase represents a material addition to her personal position, the fundamental deterioration in the business (shrinking revenues, substantial losses) and the stock's recent weakness (-5.8% over 30 days) place this transaction in context of unfavorable operating conditions rather than obvious valuation opportunity.